FENNEC PHARMACEUTICALS INC. — Revenue by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c6d6658-81e2-4355-9348-0190e56db655/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $44.6M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-036182 |
| FY 2024 | $47.5M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003710 |
| FY 2023 | $21.3M | 2023-01-01 – 2023-12-31 | evidence 0001558370-25-003710 |
| FY 2022 | $1.8M | 2022-01-01 – 2022-12-31 | evidence 0001558370-24-004383 |
| FY 2020 | $170.0k | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-002334 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-021132 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014220 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-017571 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-017299 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-090604 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-020272 |
| FY 2013 | $0 | 1996-09-03 – 2014-03-31 | evidence 0001144204-14-031132 |
| FY 2012 | $0 | 1996-09-03 – 2013-03-31 | evidence 0001144204-13-028056 |
| FY 2011 | $0 | 1996-09-03 – 2012-03-31 | evidence 0001144204-12-028850 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
FENNEC PHARMACEUTICALS INC. — all facts · Net Income · Operating Income